Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- AnGes MG to Codevelop Antibacterial Spray with Hospital Group
January 24, 2011
- JMIRI Launches Web Service for Prescription Record Analysis
January 24, 2011
- Teijin Pharma to Launch TMX-67 in Emerging Countries in 2013-2014
January 24, 2011
- Market for Drugs for Alzheimer's Disease to Reach ¥290 Bil. in 2020: Seed Planning Survey
January 24, 2011
- FJPWA to Do Utmost for Full Introduction of Premium for New Drug Development: Chairman Bessho
January 24, 2011
- 76 Actos Generics Approved from 27 Companies
January 24, 2011
- Qol Considers Introducing Point Cards for Drug Dispensing Services
January 24, 2011
- Pfizer to Market Generics of Over 20 APIs in 2011
January 24, 2011
- classA Network Considers Introducing Point Service Program
January 24, 2011
- Small Generic Makers to Increasingly Specialize in Development, Manufacturing: JGA President Sawai
January 24, 2011
- JACDS to Call on Members to Temporarily Refrain from Offering Points for Dispensing Services
January 24, 2011
- Mr Hosokawa Reappointed Health Minister
January 24, 2011
- LSIP Signs 1st Agreements for Patents on Apoptosis, Stem Cells
January 24, 2011
- Pfizer Applies for Prevnar 13 in Adult Patients in US, Europe
January 24, 2011
- Takeda Licenses Biomarker for Alzheimer's Disease from Zinfandel
January 24, 2011
- Prospects for Simultaneous Global Development: 4
January 24, 2011
- Ono Enters Target Discovery Agreement with BioFocus for Autoimmune Disease
January 24, 2011
- Minodronate vs Raloxifene to Be Compared in IIT
January 24, 2011
- Addition of Noven Boosts Sales: Hisamitsu
January 17, 2011
- AnGes MG Granted Patent for NFκB Decoy Oligo
January 17, 2011
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…